The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
wan zuo zhi liao duo fa xing gu sui liu liao xiao fen xi
Author(s): 
Pages: 2748-2750
Year: Issue:  16
Journal: The Journal of Practical Medicine

Abstract: 目的:研究万珂治疗多发性骨髓瘤疗效的影响因素.方法:20例确诊为多发性骨髓瘤的患者接受了万珂联合地塞米松的治疗,每疗程的第1、4、8、11天给予万珂每次1.3 mg/m2或1.75 mg/次,第1、2、4、5、8、9、11、12天静脉滴注地塞米松20 mg,/d,另外地塞米松0.75 mg/d 口服共12 d.两疗程之间间隔10 d.结果:(1)20例患者在1疗程后,1例达到非常好的部分缓解(VG...
Related Articles
No related articles found